Generic Name: zafirlukast
Applies to zafirlukast: oral tablet
In addition to its needed effects, some unwanted effects may be caused by zafirlukast (the active ingredient contained in Accolate). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking zafirlukast:
Some of the side effects that can occur with zafirlukast may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to zafirlukast: oral tablet
The most commons adverse effects may be associated with headache or gastrointestinal disturbances.  These symptoms are usually mild.[Ref]
Very common (10% or more): Headache (up to 12.9%)Common (1% to 10%): Dizziness (1.6%)Frequency not reported: Neuropathy, neuropsychiatric events[Ref]
Common (1% to 10%): Nausea (up to 3.1%), diarrhea (up to 2.8%), abdominal pain (up to 2.8%), vomiting (up to 1.5%), dyspepsia (1.3%)[Ref]
In most of the postmarketing reports, the patient's symptoms abated and the liver enzymes returned to normal or near normal after stopping this drug.[Ref]
Common (1% to 10%): SGPT elevation (1.5%), AST (1.4%)Rare (less than 0.1%): Hyperbilirubinemia without other elevated liver function tests; fulminant hepatitis or progressed to hepatic failure, liver transplantation and deathPostmarketing reports: Symptomatic hepatitis (with or without hyperbilirubinemia) without other attributable cause; hepatic dysfunction[Ref]
Common (1% to 10%): Myalgia (1.6%), back pain (1.5%)Frequency not reported: Arthralgia[Ref]
Common (1% to 10%): Generalized pain (1.9%), asthenia (up to 1.8%), accidental injury (1.6%), fever (1.4%)Rare (less than 0.1%): Increased theophylline levels with or without clinical signs or symptoms of theophylline toxicity when this drug was added to an existing theophylline regime.Frequency not reported: Edema, malaise[Ref]
Common (1% to 10%): Respiratory tract infection (3.5%)[Ref]
Infections were usually mild or moderate, predominantly affecting the respiratory tract and not necessitating withdrawal from the therapy.In clinical trials, an increased proportion of patients over the age of 55 years reported these infections.  Infections occurred equally in both sexes and were associated with coadministration of inhaled corticosteroids.[Ref]
Rare (less than 0.1%): Bleeding disorders including menorrhagia, thrombocytopenia[Ref]
Rare (less than 0.1%): AlopeciaFrequency not reported: Bruising, pruritus[Ref]
Rare (0.01% to 0.1%): GranulomatosisVery rare (less than 0.01%): Agranulocytosis[Ref]
Systemic eosinophilia may also involve various body systems including vasculitic rash, worsening pulmonary symptoms, cardiac complications or neuropathy.[Ref]
Rare (less than 0.1%): Systemic eosinophilia, eosinophilic pneumonia, or clinical features of vasculitis consistent with Churg-Strauss syndrome[Ref]
Frequency not reported: Urticaria, angioedema, rashes (with or without blistering)[Ref]
Frequency not reported: Insomnia, depression[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. "Product Information. Accolate (zafirlukast)." Zeneca Pharmaceuticals, Wilmington, DE. 
4. Smith LJ, Geller S, Ebright L, Glass M, Thyrum PT "Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219." Am Rev Respir Dis 141 (1990): 988-92
5. Spector SL "Leukotriene inhibitors and antagonists in asthma." Ann Allergy Asthma Immunol 75 (1995): 463-70,473-4
6. Findlay SR, Barden JM, Easley CB, Glass M "Effect of the oral leukotriene antagonist, ICI 204,219, on antigen- induced bronchoconstriction in subjects with asthma." J Allergy Clin Immunol 89 (1992): 1040-5
7. Kelloway JS "Zafirlukast: the first leukotriente-receptor antagonist approved for the treatment of asthma." Ann Pharmacother 31 (1997): 1012-21
8. Spector SL, Smith LJ, Glass M "Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group." Am J Respir Crit Care Med 150 (1994): 618-23
9. Torres M,  Reddy KR "Severe liver injury." Ann Intern Med 135 (2001): 550
10. Danese S,  De Vitis I,  Gasbarrini A "Severe Liver Injury Associated with Zafirlukast." Ann Intern Med 135 (2001): 930
11. Wechsler ME, Drazen JM "Zafirlukast and Churg-Strauss syndrome." Chest 116 (1999): 266-7
12. Finkel TH, Hunter DJ, Paisley JE, Finkel RS, Larsen GL "Drug-induced lupus in a child after treatment with zafirlukast (Accolate)." J Allerg Clin Immunol 103 (1999): 533-4
13. Wechsler ME, Garpestad E, Rlier SR, et al. "Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast." JAMA 279 (1998): 455-7
14. Wechsler ME, Drazen JM "Zafirlukast and Churg-Strauss syndrome - Reply." JAMA 279 (1998): 1950
15. Knoell DL, Lucas J, Allen JN "Churg-Strauss syndrome associated with zafirlukast." Chest 114 (1998): 332-4
16. Honsinger RW "Zafirlukast and Churg-Strauss syndrome." JAMA 279 (1998): 1949
17. Wechsler M, Drazen JM "Churg-Strauss syndome." Lancet 353 (1999): 1999
18. Churg J, Churg A "Zafirlukast and Churg-Strauss syndrome." JAMA 279 (1998): 1949-50
19. Green RL, Vayonis AG "Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment." Lancet 353 (1999): 725-6
20. Katz RS, Papernik M "Zafirlukast and Churg-Strauss syndrome." JAMA 279 (1998): 1949
Not all side effects for Accolate may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Cough or hoarseness
fever or chills
lower back or side pain
pain
painful or difficult urination


Abdominal or stomach pain
clay-colored stools
dark urine
diarrhea
dizziness
headache
itching
loss of appetite
nausea
rash
unpleasant breath odor
unusual tiredness or weakness
vomiting of blood
yellow eyes or skin


Attack, assault, or force
attempts at killing oneself
discouragement
dry mouth
fear or nervousness
feeling sad or empty
fever with or without chills
general feeling of tiredness or weakness
hyperventilation
irregular heartbeats
irritability
lack of appetite
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
loss of interest or pleasure
restlessness
seeing, hearing, or feeling things that are not there
shakiness in the legs, arms, hands, or feet
shortness of breath
sleeplessness
sore throat
sores, ulcers, or white spots on the lips or in the mouth
tiredness
trembling or shaking of the hands or feet
trouble with concentrating
trouble with sleeping
unable to sleep
unusual bleeding or bruising


Acid or sour stomach
back pain
belching
difficulty with moving
heartburn
indigestion
joint pain
lack or loss of strength
muscle aching or cramping
muscle pains or stiffness
stomach discomfort or upset
swollen joints
vomiting


Hives or welts
redness of the skin

